| DEUTETRABENAZINE | Teva | ||
| 6 mg, 12 mg, and 24 mg ; Extended-release Tablets |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
|
More Than 5
|
None | ||
| None | None | ||
| AUSTEDO XR is vesicular monoamine transporter 2 (VMAT2) inhibitors indicated in adults for the treatment of: • Chorea associated with Huntington’s disease • Tardive dyskinesia | |||
|
Yes
| |||
| AUSTEDO XR | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ***** | ******* **** *** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** |
| ************** ********** ** ********* ********* *********** * | ************ **************** ** ********** ************** ********** ** ********* ********* *********** * | ******* *** *** ********* ** ******** *********** ******** ********* | ******* *** *** ********* ** ******** *********** ******** ********* | ******* *** *** ********* ** ******** *********** ******** ********* | ******* *** *** ********* ** ******** *********** ******** ********* | ******* *** *** ********* ** ******** *********** ******** ********* | ******* *** *** ********* ** ******** *********** ******** ********* | ******* ** ****************, ***** *********** *** *** | ******* ** ****************, ***** *********** *** *** | ******* ****** ***** ********** **************** *** ******* ** *** ******* | ******* ****** ***** ********** **************** *** ******* ** *** ******* | ******* ****** ***** ********** **************** *** ******* ** *** ******* |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ***** | *** \ ********* | *** **, **** | ******* | **** | *** ****** *** **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|